Supplementary figure shows ISR pathway inhibition alters immune checkpoints in lung cancer, suggesting new therapeutic avenues.
Supplementary Figure 5 shows the effect of ISR pathway inhibition on immune cell populations in vivo.
No takes yet. Share an insight, caveat, or question.
Thomas-Jardin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: